Form 4 for ABCL AbCellera Biologics Inc.
Accepted 2026-08-14 12:04:25 ET · period of report 2026-08-14 · accession 0001834411-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 12:04 | 2026-08-14 | ABCL | Booth Andrew | CFO | P - Purchase | $10.32 | +37.2K | 482.8K | +8% | +$383.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-08-14 | P | A | 37,200 | $10.32 | 482,800 | D | — | — |